Clinical trials

  • XXX for Malignant solid tumour expressing CEACAM5 (CEA)
  • PATRITUMAB DERUXTECAN for Non-small cell lung cancer (EGFR-mutated)
  • ALFA-D-MANNOSE 1-PHOSPHATE DIPOTASSIUM for PMM2-CDG (Phosphomannomutase 2 congenital disorder of glycosylation)
  • Infliximab for Takayasu arteritis
  • DURVALUMAB for Unresectable oesophageal cancer | Oesophageal adenocarcinoma | Oesophageal squamous cell carcinoma
  • DURVALUMAB for Limited-stage small cell lung cancer
  • ULEFNERSEN for Amyotrophic lateral sclerosis (ALS) | FUS mutation-associated amyotrophic lateral sclerosis (FUS-ALS)
  • FUTIBATINIB for Malignant solid tumors
  • Clinical trial in Breast cancer
  • Doravirine; Islatravir for HIV-1 infection|HIV infection
  • Ravulizumab for IgA nephropathy | Idiopathic IgA nephropathy
  • DURVALUMAB for Hepatocellular carcinoma (advanced)